1

TORquing metabolic reprogramming in cancer cells

Year:
2016
Language:
english
File:
PDF, 926 KB
english, 2016
2

From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue

Year:
2014
Language:
english
File:
PDF, 415 KB
english, 2014
4

Communication in Drug Development: “Translating” Scientific Discovery

Year:
2016
Language:
english
File:
PDF, 375 KB
english, 2016
15

Cancer: miRNA Addiction — Depending On Life's Little Things

Year:
2010
Language:
english
File:
PDF, 44 KB
english, 2010
19

A three-drug combination to treat BRAF-mutant cancers

Year:
2017
Language:
english
File:
PDF, 1.03 MB
english, 2017
22

Rho family GTPases: more than simple switches

Year:
2000
Language:
english
File:
PDF, 102 KB
english, 2000
23

A Therapeutic Opportunity in Melanoma: ErbB4 Makes a Mark on Skin

Year:
2009
Language:
english
File:
PDF, 57 KB
english, 2009
24

Cancer: Drivers and passengers

Year:
2007
Language:
english
File:
PDF, 357 KB
english, 2007
25

Cancer: Bet on drug resistance

Year:
2016
Language:
english
File:
PDF, 183 KB
english, 2016
26

Targeting the RAF–MEK–ERK pathway in cancer therapy

Year:
2009
Language:
english
File:
PDF, 363 KB
english, 2009
28

Dissecting cancer heterogeneity

Year:
2011
Language:
english
File:
PDF, 1011 KB
english, 2011
29

Mechanisms of acquired resistance to targeted cancer therapies

Year:
2012
Language:
english
File:
PDF, 1009 KB
english, 2012
31

Optimizing the treatment of BRAF mutant melanoma

Year:
2014
Language:
english
File:
PDF, 126 KB
english, 2014
35

Discovering Tumor Suppressor Genes Through Genome-Wide Copy Number Analysis

Year:
2010
Language:
english
File:
PDF, 383 KB
english, 2010
39

Emerging concepts in tumor progression and therapy

Year:
2000
Language:
english
File:
PDF, 121 KB
english, 2000
40

Oncogenic K-ras “addiction” and synthetic lethality

Year:
2009
Language:
english
File:
PDF, 611 KB
english, 2009